These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Scheil S; Brüderlein S; Eicker M; Herms J; Herold-Mende C; Steiner HH; Barth TF; Möller P Brain Pathol; 2001 Apr; 11(2):133-43. PubMed ID: 11303789 [TBL] [Abstract][Full Text] [Related]
4. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150 [TBL] [Abstract][Full Text] [Related]
5. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of chromosome 1q gain in intracranial ependymomas. Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097 [TBL] [Abstract][Full Text] [Related]
7. Utility of copy number variants in the classification of intracranial ependymoma. Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935 [TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Grill J; Avet-Loiseau H; Lellouch-Tubiana A; Sévenet N; Terrier-Lacombe MJ; Vénuat AM; Doz F; Sainte-Rose C; Kalifa C; Vassal G Cancer Genet Cytogenet; 2002 Jul; 136(2):121-5. PubMed ID: 12237235 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic study of 33 ependymomas. Vagner-Capodano AM; Zattara-Cannoni H; Gambarelli D; Figarella-Branger D; Lena G; Dufour H; Grisoli F; Choux M Cancer Genet Cytogenet; 1999 Dec; 115(2):96-9. PubMed ID: 10598140 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review. Nobusawa S; Hirato J; Yokoo H Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241 [TBL] [Abstract][Full Text] [Related]
12. [Detection of chromosomal imbalance in ependymoma by comparative genomic hybridization]. Wu WX; Yu SZ; Sun CY; Wang Q; Jin SM; An TL Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):148-52. PubMed ID: 19575847 [TBL] [Abstract][Full Text] [Related]
13. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631 [TBL] [Abstract][Full Text] [Related]
14. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis. Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups. Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101 [TBL] [Abstract][Full Text] [Related]
16. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662 [TBL] [Abstract][Full Text] [Related]
17. Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain. Gojo J; Lötsch D; Spiegl-Kreinecker S; Pajtler KW; Neumayer K; Korbel P; Araki A; Brandstetter A; Mohr T; Hovestadt V; Chavez L; Kirchhofer D; Ricken G; Stefanits H; Korshunov A; Pfister SM; Dieckmann K; Azizi AA; Czech T; Filipits M; Kool M; Peyrl A; Slavc I; Berger W; Haberler C Neuro Oncol; 2017 Sep; 19(9):1183-1194. PubMed ID: 28371821 [TBL] [Abstract][Full Text] [Related]
18. Genomic characterization of ependymomas reveals 6q loss as the most common aberration. Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P Oncol Rep; 2014 Aug; 32(2):483-90. PubMed ID: 24939246 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983 [TBL] [Abstract][Full Text] [Related]
20. Supratentorial ependymoma in childhood: more than just RELA or YAP. Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]